NRx Pharmaceuticals, Inc.
NRXP
$2.35
$0.083.52%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 336.45% | 53.32% | 320.62% | -68.60% | -81.51% |
| Total Receivables | 55,333.33% | -- | -- | -- | 0.00% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -10.52% | -57.18% | -5.23% | 104.96% | -26.40% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -8.31% | -27.13% | -5.40% | -57.58% |
| Total Current Assets | 190.96% | -5.94% | 116.79% | -52.03% | -68.63% |
|
|
|||||
| Total Current Assets | 190.96% | -5.94% | 116.79% | -52.03% | -68.63% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -31.74% | -37.50% | -24.26% | -19.03% | 1,595.24% |
| Total Assets | 236.08% | -8.09% | 100.37% | -50.09% | -65.96% |
|
|
|||||
| Total Accounts Payable | -12.52% | -27.62% | -31.19% | -10.84% | 34.01% |
| Total Accrued Expenses | -5.10% | -16.31% | -5.37% | 224.19% | 8.73% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 231.08% | 28.79% | 23.87% | -86.40% | -69.71% |
| Total Finance Division Other Current Liabilities | 213.83% | 447.24% | 55,926.92% | 93,976.47% | 1,942.28% |
| Total Other Current Liabilities | 213.83% | 447.24% | 55,926.92% | 93,976.47% | 1,942.28% |
| Total Current Liabilities | 99.98% | 71.01% | 73.68% | 14.78% | 5.03% |
|
|
|||||
| Total Current Liabilities | 99.98% | 71.01% | 73.68% | 14.78% | 5.03% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 75.02% | 71.01% | 73.68% | 41.09% | 20.47% |
|
|
|||||
| Common Stock & APIC | 12.43% | 6.65% | 5.73% | 5.65% | 3.20% |
| Retained Earnings | -14.14% | -12.63% | -9.28% | -9.93% | -8.19% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -36.83% | -93.65% | -66.97% | -97.88% | -202.60% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -36.83% | -93.65% | -66.97% | -97.88% | -202.60% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -36.83% | -93.65% | -66.97% | -97.93% | -202.75% |
|
|
|||||